Summary
- Profile Type
- Technology offer
- POD Reference
- TODE20250120020
- Term of Validity
- 3 February 2025 - 3 February 2026
- Company's Country
- Germany
- Type of partnership
- Commercial agreement with technical assistance
- Research and development cooperation agreement
- Investment agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The German company with focus on projects VR and 3D visualization has created a publicly funded concept for Clinical Interactive Exposure Therapy (CIET), an innovative tool designed to support therapists in treating anxiety and trauma disorders. The company is now seeking a healthcare sector partner to scale up the CIET project, ensuring it becomes a practical and impactful solution for therapeutic use.
- Full Description
-
The Cologne-based game development studio specializes in creating applied games and virtual tools that address fears and anxiety, particularly in therapeutic settings. Their work emphasizes recreational fear experiences as a method for coping with fear, earning them public funding and recognition. Over time, the studio has shifted its focus toward developing tools for healthcare professionals to support therapy for anxiety disorders and trauma.
The studio collaborates closely with therapists specializing in anxiety and trauma to ensure its solutions meet real-world therapeutic needs. This collaboration incorporates real-life challenges faced by therapists in practice as well as healthcare preferences and established methods to ensure compatibility.
The system is designed as a therapeutic aid for guided use during therapy sessions, not for standalone use by patients at home.
The team has a strong portfolio of VR and applied game projects, including:
- VR training for firefighters to simulate gear use in high-stress environments;
- VR first-aid training for emergency scenarios;
- 3D visualization of the “Project Hafenbrücken” bridge construction in Nürnberg;
- Custom virtual therapy spaces designed in collaboration with partner therapists.
As a development studio, the company acknowledges its sector-specific limitations and seeks partners in healthcare sector with the expertise and resources to co-develop and scale the system for broader implementation. Ideal partners will possess a shared commitment to innovation and a willingness to collaboratively address challenges, ensuring the successful commercialization of the project. - Advantages and Innovations
-
The tool is uniquely designed for therapists, not patients, offering a system that adapts dynamically to individual patient-therapist interactions during sessions. This personalized approach ensures flexibility and alignment with diverse therapeutic needs.
The concept has already gained validation and financial support from a German public funding body, which has expressed interest in further backing the project—highlighting its potential and credibility.
The team is committed to developing a commercially viable system that adheres to EU healthcare standards, ensuring compliance, safety, and wide applicability in clinical settings.
Early-stage partnerships offer a unique opportunity for greater influence and ownership, allowing collaborators to shape the project as it evolves into a scalable and impactful solution. - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 4: Quality Education
- Goal 9: Industry, Innovation and Infrastructure
- Goal 17: Partnerships to achieve the Goal
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
-
The company is actively seeking collaborative partnerships with organizations in the healthcare sector to bring its innovative solutions to market:
1. Research Partners
Phase 1: theoretical research - study the integration of digital tools in therapy practices, assess therapists’ openness to new technologies, and identify barriers to adoption.
Phase 2: practical research - testing the prototype in trial therapy settings with the target group to evaluate its effectiveness and usability.
2. Development and funding partners
Prototype development - collaboration with a partner to refine and systematize the tool, ensuring it aligns with the healthcare system’s specific requirements.
Co-Funding - securing a partner to co-fund development alongside public funding opportunities.
3. Infrastructure and distribution expertise: identification a partner with deep knowledge of healthcare tech infrastructure and distribution to scale the system post-development. - Type and Size of Partner
- R&D Institution
- SME 50 - 249
- SME 11-49
- University
- SME <=10
- Big company
- Other
- Type of partnership
- Commercial agreement with technical assistance
- Research and development cooperation agreement
- Investment agreement
Dissemination
- Technology keywords
- 06001012 - Medical Research
- 01005006 - Visualisation, Virtual Reality
- 01004014 - Serious Games
- Market keywords
- 02007010 - Education software
- 02007022 - Software services
- 02007012 - Medical/health software
- 05003001 - Therapeutic services
- Sector Groups Involved
- Health
- Creative Industries
- Digital
- Targeted countries
- All countries